2024. Deucravacitinib in Moderate to Severe Plaque Psoriasis: Comorbidities and Use of Prior and Concomitant Medication in Patients Enrolled in the Phase 3 POETYK PSO-1 and PSO-2 Trials. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s428. DOI:https://doi.org/10.25251/skin.8.supp.428.